Drug profile · INN
trastuzumab
HERVELOUS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
trastuzumab (HERVELOUS) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN trastuzumab
Brand HERVELOUS
Route INTRAVENOUS
Formulation VIAL
ATC code L01FD01
Frequently asked questions
What is trastuzumab?
trastuzumab (HERVELOUS) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for trastuzumab?
HERVELOUS is a marketed brand name for trastuzumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trastuzumab?
trastuzumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.